[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prostate-cancer-after-a-radical-treatment\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prostate-cancer-after-a-radical-treatment":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100566588","diagnostic-performance-of-18fpsma-1007-in-the-context-of-biochemical-recurrence-of-prostate-cancer-100566588",false,"NCT06657131","Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer","Diagnostic Performance and Clinical Impact of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer: a Real-World Evidence from a Monocentric, Prospective Observational Phase-4-Trial","[18F]PSMA-1007","Inclusion Criteria:\n\n* Informed Consent\n* Conduct of \\[18F\\]PSMA-1007 PET Imaging in the context of regular clinical care\n\nExclusion Criteria:\n\n* Technical Flaws in the acquisition protocol","MALE","18 Years",{"count":20,"type":21},250,"ESTIMATED","OBSERVATIONAL","Following numerous retrospective studies and Phase-3-Studies with promising results, \\[18F\\]PSMA-1007 has been approved by european authorities. Therefore, it is a growing deployment of this diagnostic method anticipated. This study aims to investigate the diagnostic performance and clinical impact in a real-world-evidence in the context of regular clinical care. The evidence generated by this approach is supposed to assist in optimizing the management of prostate cancer patients.",[25,26,27],"Prostate Cancer After a Radical Treatment","Biochemical Recurrence of Malignant Neoplasm of Prostate","Biochemical Persistence of Prostate Cancer",[29,30,31,15,32],"prostate cancer","biochemical recurrence","18F-PSMA-1007","biochemical persistence","RECRUITING","2025-01-16",{"date":36,"type":37},"2025-01-17","ACTUAL",{"date":39,"type":37},"2024-11-01",{"date":41,"type":21},"2028-11-30",{"name":43,"class":44},"Heinrich-Heine University, Duesseldorf","OTHER"]